NEOQUASSIN, .ALPHA.-
UNII CKZ8SB07ER

Substance Identification & Data

This profile provides standardized clinical and technical data for Neoquassin, .alpha.-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CKZ8SB07ER.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 88980-55-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CKZ8SB07ER

CAS Registry Number

88980-55-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NEOQUASSIN, .ALPHA.-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H30O6

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BDQNCUODBJZKIY-BILCURGMSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

86278224

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C[C@]12[C@]3([H])C(C)=C(OC)C(=O)[C@]1([H])[C@]4(C(=O)C(OC)=C[C@@H](C)[C@]4([H])C[C@@]2([H])O[C@@H](O)C3)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Neoquassin, .alpha.-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.